Pfizer Stock Rises Wednesday: What's Going On?
In brief
Pfizer’s stock gains reflect growing confidence in mRNA cancer treatments after Merck and Moderna’s breakthrough melanoma trial.
ClearTape summarizes context in-app. For the full publisher article, use Read original source above.